Nexalin Technology Stock Performance
| NXL Stock | USD 0.40 0.05 11.11% |
The company secures a Beta (Market Risk) of 1.42, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nexalin Technology will likely underperform. At this point, Nexalin Technology has a negative expected return of -1.32%. Please make sure to verify Nexalin Technology's potential upside and rate of daily change , to decide if Nexalin Technology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Nexalin Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
1 | Insider Trading | 11/26/2025 |
2 | Acquisition by Owens David of 654363 shares of Nexalin Technology at 0.894 subject to Rule 16b-3 | 02/02/2026 |
3 | Nexalin Launches NeuroCare, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimers, Mood Disorders, TBI PTSD Care | 02/05/2026 |
| Begin Period Cash Flow | 580.2 K | |
| Total Cashflows From Investing Activities | -577.5 K |
Nexalin Technology Relative Risk vs. Return Landscape
If you would invest 98.00 in Nexalin Technology on November 20, 2025 and sell it today you would lose (58.00) from holding Nexalin Technology or give up 59.18% of portfolio value over 90 days. Nexalin Technology is generating negative expected returns assuming volatility of 6.1507% on return distribution over 90 days investment horizon. In other words, 55% of stocks are less volatile than Nexalin, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Nexalin Technology Target Price Odds to finish over Current Price
The tendency of Nexalin Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.40 | 90 days | 0.40 | over 95.79 |
Based on a normal probability distribution, the odds of Nexalin Technology to move above the current price in 90 days from now is over 95.79 (This Nexalin Technology probability density function shows the probability of Nexalin Stock to fall within a particular range of prices over 90 days) .
Nexalin Technology Price Density |
| Price |
Predictive Modules for Nexalin Technology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nexalin Technology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nexalin Technology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nexalin Technology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nexalin Technology is not an exception. The market had few large corrections towards the Nexalin Technology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nexalin Technology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nexalin Technology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.59 | |
β | Beta against Dow Jones | 1.42 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | -0.26 |
Nexalin Technology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nexalin Technology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nexalin Technology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nexalin Technology generated a negative expected return over the last 90 days | |
| Nexalin Technology has high historical volatility and very poor performance | |
| Nexalin Technology has some characteristics of a very speculative penny stock | |
| Nexalin Technology has a very high chance of going through financial distress in the upcoming years | |
| Nexalin Technology has 546.69 K in debt. Nexalin Technology has a current ratio of 0.2, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. That said, strategic use of leverage may enable Nexalin to fund expansion initiatives and generate superior returns. | |
| The entity reported the last year's revenue of 168.72 K. Reported Net Loss for the year was (7.61 M) with profit before taxes, overhead, and interest of 109.09 K. | |
| Nexalin Technology has about 291.33 K in cash with (3.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Nexalin Technology has a frail financial position based on the latest SEC disclosures | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Insider Trading |
Nexalin Technology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nexalin Stock often depends not only on the future outlook of the current and potential Nexalin Technology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nexalin Technology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.2 M | |
| Cash And Short Term Investments | 3.5 M |
Nexalin Technology Fundamentals Growth
Nexalin Stock prices reflect investors' perceptions of the future prospects and financial health of Nexalin Technology, and Nexalin Technology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nexalin Stock performance.
| Return On Equity | -1.78 | ||||
| Return On Asset | -1.07 | ||||
| Operating Margin | (129.24) % | ||||
| Current Valuation | 5.24 M | ||||
| Shares Outstanding | 18.65 M | ||||
| Price To Book | 1.72 X | ||||
| Price To Sales | 53.79 X | ||||
| Revenue | 168.72 K | ||||
| Gross Profit | 109.09 K | ||||
| EBITDA | (7.74 M) | ||||
| Net Income | (7.61 M) | ||||
| Cash And Equivalents | 291.33 K | ||||
| Cash Per Share | 0.06 X | ||||
| Total Debt | 546.69 K | ||||
| Current Ratio | 0.20 X | ||||
| Book Value Per Share | 0.26 X | ||||
| Cash Flow From Operations | (3.94 M) | ||||
| Earnings Per Share | (0.67) X | ||||
| Market Capitalization | 8.44 M | ||||
| Total Asset | 4.22 M | ||||
| Retained Earnings | (84.65 M) | ||||
| Working Capital | 3.41 M | ||||
About Nexalin Technology Performance
By examining Nexalin Technology's fundamental ratios, stakeholders can obtain critical insights into Nexalin Technology's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nexalin Technology is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 1.6 K | 1.6 K | |
| Return On Tangible Assets | (1.73) | (1.81) | |
| Return On Capital Employed | (2.43) | (2.30) | |
| Return On Assets | (1.62) | (1.70) | |
| Return On Equity | (2.38) | (2.26) |
Things to note about Nexalin Technology performance evaluation
Checking the ongoing alerts about Nexalin Technology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nexalin Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nexalin Technology generated a negative expected return over the last 90 days | |
| Nexalin Technology has high historical volatility and very poor performance | |
| Nexalin Technology has some characteristics of a very speculative penny stock | |
| Nexalin Technology has a very high chance of going through financial distress in the upcoming years | |
| Nexalin Technology has 546.69 K in debt. Nexalin Technology has a current ratio of 0.2, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. That said, strategic use of leverage may enable Nexalin to fund expansion initiatives and generate superior returns. | |
| The entity reported the last year's revenue of 168.72 K. Reported Net Loss for the year was (7.61 M) with profit before taxes, overhead, and interest of 109.09 K. | |
| Nexalin Technology has about 291.33 K in cash with (3.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Nexalin Technology has a frail financial position based on the latest SEC disclosures | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Insider Trading |
- Analyzing Nexalin Technology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nexalin Technology's stock is overvalued or undervalued compared to its peers.
- Examining Nexalin Technology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nexalin Technology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nexalin Technology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nexalin Technology's stock. These opinions can provide insight into Nexalin Technology's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. Anticipated expansion of Nexalin directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexalin Technology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth (0.50) | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nexalin Technology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexalin Technology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nexalin Technology's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.